Skip to main content
. 2019 Jan 25;9(1):e024180. doi: 10.1136/bmjopen-2018-024180

Table 3.

Risk of pneumonia after stroke according to different cumulative BZD doses

Cumulative BZD doses n Pneumonia cases Person- years Incidence rate* Univariate model Multivariate model†
Crude HR (95% CI) P value Adjusted HR (95% CI) P value
Non-user 3758 478 14 663.8 32.6 1 (ref) 1 (ref)
1–90 cDDDs 2507 702 11 760.2 59.7 2.10 (1.87 to 2.36) <0.001 2.28 (2.01 to 2.58) <0.001
91–365 cDDDs 728 198 4216.6 47.0 1.84 (1.56 to 2.16) <0.001 2.09 (1.77 to 2.47) <0.001
>365 cDDDs 523 127 3703.4 34.3 1.47 (1.21 to 1.77) <0.001 2.08 (1.72 to 2.52) <0.001

*Per 1000 person-years.

†Multivariate Cox proportional hazard regression model, adjusting for all baseline characteristics (listed in table 1) and competing mortality.

BZD, benzodiazepine; cDDDs, cumulative defined daily doses.